Kurt Azarbarzin

Kurt Azarbarzin is President and Chief Executive Officer of Verb Surgical, Inc. and a member of the board of directors. He brings over 30 years of medical device industry and surgery market experience to the company. In his most recent role, he was Chief Technology Officer at ConMed Corporation, a global, publically-traded medical company specializing in surgical and patient monitoring technology. Prior to ConMed, Mr. Azarbarzin was the founder and Chief Executive Officer of SurgiQuest, Inc., a venture-backed medical device company that developed and commercialized innovative technologies for minimally invasive and robotic surgery, including the AirSeal® platform, and was later successfully acquired by ConMed. Prior to SurgiQuest, Mr. Azarbarzin held numerous Research and Development leadership positions at Covidien (now part of Medtronic). He currently serves as Chairman of the Board of Directors at Standard Bariatrics, Inc and is a member of the Executive Board at the Center for Biomedical Innovation and Technology at Yale University. Mr. Azarbarzin earned a Bachelor of Science from the University of Bridgeport and completed advanced graduate studies in mechanical design at Bridgeport Engineering Institute and manufacturing engineering at Bradley University.